The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 6,750,500 | 25,000 | SH | Put | SOLE | 25,000 | 0 | 0 | |
| ALPHA COGNITION INC | COM NEW | 02074J501 | 897,725 | 177,416 | SH | SOLE | 177,416 | 0 | 0 | ||
| ANTERIS TECHNOLOGIES GLOBAL | COM | 03675P102 | 613,664 | 168,589 | SH | SOLE | 168,589 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | COM SHS | G29687103 | 3,281,796 | 419,131 | SH | SOLE | 419,131 | 0 | 0 | ||
| BETTER CHOICE CO INC | COM NEW | 08771Y402 | 67,052 | 38,984 | SH | SOLE | 38,984 | 0 | 0 | ||
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | 2,120,922 | 303,857 | SH | SOLE | 303,857 | 0 | 0 | ||
| ENVVENO MEDICAL CORPORATION | COM | 29415J106 | 324,163 | 123,256 | SH | SOLE | 123,256 | 0 | 0 | ||
| ESSA PHARMA INC | COM NEW | 29668H708 | 1,659,583 | 1,050,369 | SH | SOLE | 1,050,369 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 3,563,202 | 296,193 | SH | SOLE | 296,193 | 0 | 0 | ||
| INTELLIGENT BIO SOLUTIONS IN | COM | 36151G600 | 214,923 | 149,252 | SH | SOLE | 149,252 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | 184,505 | 49,333 | SH | SOLE | 49,333 | 0 | 0 | ||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | 587,389 | 273,204 | SH | SOLE | 273,204 | 0 | 0 | ||
| LOGICMARK INC | COM NEW | 67091J602 | 106,827 | 5,395,308 | SH | SOLE | 5,395,308 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 714,938 | 1,051,379 | SH | SOLE | 1,051,379 | 0 | 0 | ||
| PROFOUND MED CORP | COM NEW | 74319B502 | 2,098,628 | 360,589 | SH | SOLE | 360,589 | 0 | 0 | ||
| PROMIS NEUROSCIENCES INC | COM NEW | 74346M406 | 399,389 | 574,248 | SH | SOLE | 574,248 | 0 | 0 | ||
| REZOLUTE INC | COM NEW | 76200L309 | 881,452 | 303,949 | SH | SOLE | 303,949 | 0 | 0 | ||
| SHARPS TECHNOLOGY INC | COM NEW | 82003F200 | 110,405 | 4,044,149 | SH | SOLE | 4,044,149 | 0 | 0 | ||
| SKYE BIOSCIENCE INC | COM NEW | 83086J200 | 1,438,735 | 904,865 | SH | SOLE | 904,865 | 0 | 0 | ||
| SUNSHINE BIOPHARMA INC | COM | 867781700 | 96,390 | 50,466 | SH | SOLE | 50,466 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 315,370 | 9,400 | SH | Call | SOLE | 0 | 0 | 0 | |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 2,021,421 | 60,251 | SH | SOLE | 60,251 | 0 | 0 | ||
| XTANT MED HLDGS INC | COM NEW | 98420P308 | 3,408,909 | 7,252,998 | SH | SOLE | 7,252,998 | 0 | 0 | ||
| ZEVRA THERAPEUTICS INC | COM NEW | 488445206 | 9,642,124 | 1,287,333 | SH | SOLE | 1,287,333 | 0 | 0 | ||